This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| H7N9 outbreak | |
|---|---|
| Name | H7N9 outbreak |
| Field | Virology, Infectious disease, Epidemiology |
| Symptoms | Fever, cough, pneumonia |
| Complications | Acute respiratory distress syndrome, multi-organ failure |
| Onset | Incubation period 1–10 days |
| Duration | Variable |
| Causes | Avian influenza A(H7N9) virus |
| Risks | Poultry exposure, live markets, age, comorbidity |
| Diagnosis | RT-PCR, viral culture, serology |
| Prevention | Poultry market closures, vaccination, personal protective equipment |
| Treatment | Antivirals (neuraminidase inhibitors), supportive care |
| Deaths | Variable (case fatality fluctuates by wave) |
H7N9 outbreak The H7N9 outbreak refers to recurrent human infections caused by avian influenza A(H7N9) virus first detected in China in 2013 and associated with zoonotic spillover from poultry and live bird markets. The event linked public health institutions such as the World Health Organization, Chinese Center for Disease Control and Prevention, and regional public health bureaus with research organizations including the Centers for Disease Control and Prevention and academic centers studying influenza virology, surveillance, and pandemic preparedness.
The initial emergence in Shanghai, Zhejiang, and Jiangsu provinces in 2013 followed prior avian influenza events like the H5N1 avian influenza detections and drew parallels with outbreaks investigated by WHO teams after SARS and MERS. Investigation involved collaborations among China CDC, World Organisation for Animal Health, and university laboratories across Beijing, Nanjing, and Guangzhou, building on prior research from institutions such as Fudan University, Peking University, and the University of Hong Kong. Early epidemiologic links to live poultry markets and wild bird migratory flyways prompted engagement from ministries including the Ministry of Agriculture and Rural Affairs (China) and provincial health commissions.
Avian influenza A(H7N9) is an influenza A virus subtype within the Orthomyxoviridae family, genetically characterized by hemagglutinin (H7) and neuraminidase (N9) surface proteins; genomic analyses were conducted by teams at Chinese Academy of Sciences laboratories and international partners like the CDC (United States). Studies in virology labs at Wuhan Institute of Virology, Institut Pasteur, and National Institute for Biological Standards and Control evaluated receptor binding, showing affinity shifts involving alpha-2,3 sialic acid and alpha-2,6 sialic acid residues similar to findings from H1N1 and H5N1 research. Transmission was primarily zoonotic via exposure to infected poultry in live bird markets with limited evidence for sustained human-to-human spread; investigations referenced methods used in assessments after the 1918 influenza pandemic and modeled by groups at Imperial College London and Johns Hopkins University.
Surveillance documented multiple epidemic waves with notable activity in spring 2013, winter 2013–2014, and later peaks in 2016–2017 and 2017–2018, tracked by surveillance networks including WHO Global Influenza Surveillance and Response System, FluNet, and national reporting systems in China. Case counts, hospitalizations, and fatalities were compiled by China CDC and reported in peer-reviewed literature from institutions such as Lancet, New England Journal of Medicine, and Nature. Geographic spread involved urban centers like Shanghai, Hangzhou, and Nanjing as well as rural markets in Guangxi and Sichuan, while international concern led to airport screening initiatives similar to measures used during the 2009 H1N1 pandemic.
Patients typically presented with fever, cough, dyspnea, and radiographic pneumonia progressing to acute respiratory distress and multi-organ dysfunction in severe cases; clinical descriptions were documented by hospitals including Peking Union Medical College Hospital and Zhongshan Hospital. Laboratory confirmation relied on reverse transcription polymerase chain reaction performed at reference laboratories such as the China CDC National Influenza Center and viral isolation methods analogous to those used for avian influenza diagnostics at US CDC and European Centre for Disease Prevention and Control facilities. Differential diagnosis included other respiratory pathogens monitored by networks like Global Outbreak Alert and Response Network and clinical management referenced guidelines from organizations including WHO and national health commissions.
Antiviral therapy primarily involved neuraminidase inhibitors such as oseltamivir with treatment protocols informed by clinical trials and observational studies from academic centers like Fudan University and Peking University First Hospital; resistance monitoring was performed by reference labs affiliated with WHO Collaborating Centres for Influenza. Preventive measures emphasized closure or regulation of live poultry markets, poultry vaccination campaigns coordinated by the Ministry of Agriculture and Rural Affairs (China) and veterinary services, personal protective equipment recommended by WHO and CDC (United States), and risk communication via platforms like Global Health Security Agenda partnerships. Research on candidate H7 vaccines involved manufacturers and regulatory agencies including GlaxoSmithKline, Sanofi Pasteur, and the U.S. Food and Drug Administration.
Responses combined surveillance, market interventions, poultry culling, and international reporting through WHO mechanisms and bilateral coordination with agencies such as FAO and OIE (World Organisation for Animal Health). Public health measures drew on experience from SARS and H5N1 control strategies and involved local authorities in Shanghai Municipal Health Commission and provincial CDCs implementing market closures and biosecurity upgrades. Modeling and policy input came from institutions like Imperial College London, Johns Hopkins Bloomberg School of Public Health, and the National Health Commission (China), while emergency preparedness frameworks from organizations including WHO and the Global Health Security Agenda guided resource allocation and communication.
The outbreak affected poultry trade, market economies in provinces such as Zhejiang and Jiangsu, and consumer behavior in cities including Shanghai and Beijing, prompting compensation schemes administered by provincial agriculture bureaus and economic analyses by think tanks linked to World Bank and Asian Development Bank. Public confidence and international trade were influenced by reporting to World Trade Organization-related mechanisms and veterinary export controls coordinated with OIE. Long-term impacts stimulated investments in surveillance, vaccine research at institutions such as National Institutes of Health and Institut Pasteur, and policy reforms within ministries including the Ministry of Agriculture and Rural Affairs (China) and provincial health commissions.
Category:Avian influenza Category:2013 disease outbreaks